This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Stryker accuses German rival Fiagon of patent infringement at USITC

( April 21, 2025, 17:49 GMT | Official Statement) -- MLex Summary: Stryker Corp. asked the US International Trade Commission on Friday to bar the importation of German rival Fiagon AG Medical Technologies’ balloon dilation devices, used to treat sinuses, in a complaint alleging violations of Section 301 of the Tariff Act. Stryker claimed that Fiagon’s VenSure dilation devices infringe Stryker’s patents for its own XprESS dilation device. The company seeks an exclusion order as well as a cease-and-desist to halt importation, sales and advertising. The commission will solicit comments relating to the public interest, including whether barring the importation of VenSure devices would harm public health, safety or welfare. Stryker argued that its own devices could replace Fiagon’s in the marketplace and that an exclusion order would not adversely impact consumers.See the complaint attached....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections